Brain Stimulation for Mild Cognitive Impairment
Trial Summary
What is the purpose of this trial?
The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: * whether it is possible to restore various cognitive functions in older adults diagnosed with MCI by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and * whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS. Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game. Researchers will compare the effects of sham, closed-loop, and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.
Will I have to stop taking my current medications?
If you are currently taking medications that affect the mind or enhance cognition, like certain anxiety or memory drugs, you will need to stop taking them to join this trial.
What data supports the effectiveness of the treatment Closed-Loop Brain Stimulation, Non-Invasive Brain Stimulation, Transcranial Magnetic Stimulation (TMS), Theta Burst Stimulation (TBS), Brain-Computer Interface (BCI) Driven Stimulation for mild cognitive impairment?
Research shows that theta burst stimulation (TBS), a type of non-invasive brain stimulation, can improve memory and brain connectivity in people with mild cognitive impairment (MCI). Another study found that TBS improved cognitive function in patients with Parkinson's disease who also had MCI, suggesting it may have broader benefits for cognitive health.12345
Is brain stimulation safe for humans?
Brain stimulation techniques like transcranial magnetic stimulation (TMS) and theta burst stimulation (TBS) are generally considered safe, with most adverse events being mild and occurring in a small percentage of people. However, there is a potential risk of seizures, especially with TBS, so it should be used with caution.56789
How is Closed-Loop Brain Stimulation different from other treatments for mild cognitive impairment?
Closed-Loop Brain Stimulation is unique because it combines non-invasive techniques like Transcranial Magnetic Stimulation (TMS) and Brain-Computer Interface (BCI) to potentially enhance cognitive function by targeting specific brain areas, unlike traditional treatments that may not be as precise.34101112
Research Team
José del R. Millán, PhD
Principal Investigator
University of Texas at Austin
Robin Hilsabeck, PhD, ABPP
Principal Investigator
University of Texas at Austin
Eligibility Criteria
This trial is for healthy adults aged 18-35 and older adults aged 60-90 with mild cognitive impairment (MCI) who have at least an elementary school education, normal or corrected vision, and good general health. Participants must score at least 23 on the Montreal Cognitive Assessment. Those with EEG/TMS acquisition issues, MRI contraindications, neurological/psychiatric diseases, or using certain psychotropic/cognitive enhancing medications cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive theta burst stimulation (TBS) while playing a cognitive video game, with brain-computer interface (BCI) monitoring and triggering TBS based on engagement.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with cognitive assessments conducted up to 8 weeks post-intervention.
Treatment Details
Interventions
- Closed-Loop Brain Stimulation
Closed-Loop Brain Stimulation is already approved in United States, European Union for the following indications:
- Resistant Depression
- Obsessive Compulsive Disorder
- Migraine
- Resistant Depression
- Obsessive Compulsive Disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor